Volume 29, Issue 27, 2022
Meet the Editorial Board Member
Pp: 4629-4629
Author(s): Fabian Kiessling
DOI: 10.2174/092986732927220629140627
Published on: 29 June, 2022
Promising Targets and Strategies to Control Neuroinflammation (Part I)
Pp: 4630-4630
Author(s): Stephanie Federico and Stefano Moro
DOI: 10.2174/092986732927220629150904
Published on: 29 June, 2022
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Pp: 4631-4697
Author(s): Teresa Gianferrara, Eleonora Cescon, Ilenia Grieco, Giampiero Spalluto and Stephanie Federico*
DOI: 10.2174/0929867329666220216113517
Published on: 30 March, 2022
Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders
Pp: 4698-4737
Author(s): Daniela Catarzi, Flavia Varano, Erica Vigiani, Catia Lambertucci, Andrea Spinaci, Rosaria Volpini and Vittoria Colotta*
DOI: 10.2174/0929867329666220301115124
Published on: 05 April, 2022
Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways
Pp: 4738-4755
Author(s): Giambattista Marotta, Filippo Basagni, Michela Rosini and Anna Minarini*
DOI: 10.2174/0929867329666211221153719
Published on: 12 January, 2022
Computational Strategies to Identify New Drug Candidates against Neuroinflammation
Pp: 4756-4775
Author(s): Matteo Pavan, Davide Bassani, Giovanni Bolcato, Maicol Bissaro, Mattia Sturlese and Stefano Moro*
DOI: 10.2174/0929867329666220208095122
Published on: 30 March, 2022
